
Tags Archive Navigation
icon
-
Negative impact of the IRA on patient access to innovative treatments
-
Novartis Entresto receives positive CHMP opinion for pediatric heart failure
-
Novartis completes tender offer for all outstanding shares of The Medicines Company
-
Novartis successfully completes acquisition of The Medicines Company, adding a potentially first-in-class, investigational cholesterol-lowering therapy inclisiran
-
Novartis receives simultaneous approval for five new products from Japanese Ministry of Health, Labour and Welfare, offering Japanese patients a broad range of novel treatment options
-
Surviving with heart failure
-
Most Europeans have limited awareness about heart failure
-
Living with HFpEF – a patient’s story
-
Living with heart failure
-
Heart failure: coping with one of the world’s biggest killers
-
Caring for someone with heart failure
-
AI Nurse evolving for heart failure patients in China